ArticleThe protein journal2026

Biophysical Characterization of an Engineered CD80 Variant for CTLA-4 Blockade in Cancer Immunotherapy.

Zahra Hajihassan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.